Coronary Artery Disease

Type 2 myocardial infarction and myocardial injury: eligibility for novel medical therapy to derisk clinical trials
Robert Sykes, Michael Briscoe, Thomas Krysztofiak, Oliver Peck, Kenneth Mangion, Colin Berry

Open Heart Jun 2021, 8 (1) e001633; DOI: 10.1136/openhrt-2021-001633
Diagnostic role of coronary CT angiography in paroxysmal or first diagnosed atrial fibrillation
Dennis Rottländer, Martin Saal, Hubertus Degen, Miriel Gödde, Marc Horlitz, Michael Haude

Open Heart May 2021, 8 (1) e001638; DOI: 10.1136/openhrt-2021-001638
Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease
Daniel Steffens, Peter Bramlage, Julia Müller, Cornelia Dorn, W Dieter Paar, Celine Scheeff, Mario Kasner, U Rauch-Kröhnert

Open Heart May 2021, 8 (1) e001572; DOI: 10.1136/openhrt-2021-001572
Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
Ragnhild Helseth, Ola Kleveland, Thor Ueland, Rune Wiseth, Jan Kristian Damas, Kaspar Broch, Annika Michelsen, Bjørn Bendz, Lars Gullestad, Pål Aukrust, Ingebjørg Seljeflot

Open Heart May 2021, 8 (1) e001492; DOI: 10.1136/openhrt-2020-001492
Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging
Senthil Selvaraj, Muhammad Shoaib Khan, Mahesh K Vidula, Philip C Wiener, Alejandro E de Feria, Chaitanya Rojulpote, Sheela Krishnan, Ruth Tamrat, Howard Julien, Douglas Jacoby, Harold Litt, Daniel Pryma, Jacob Dubroff, Marie A Guerraty, Paco Bravo

Open Heart May 2021, 8 (1) e001648; DOI: 10.1136/openhrt-2021-001648
Icosapent ethyl: scientific and legal controversies
Gregory Curfman, Emile Shehada

Open Heart Apr 2021, 8 (1) e001616; DOI: 10.1136/openhrt-2021-001616
Reintroduction of elective cardiac interventions in the era of COVID-19: the Barts experience
Stephen Hamshere, Katrina Comer, Fizzah Choudhry, Krishna Rathod, Gordon Mills, Gordon Ferguson, Jonathan Lambourne, Majid Akhtar, Andrew Wragg, Mick Ozkor, Oliver Guttmann, Michael Mullen, Andreas Baumbach, Elliot Smith, Anthony Mathur, Dan Jones

Open Heart Apr 2021, 8 (1) e001446; DOI: 10.1136/openhrt-2020-001446
Cardiovascular risk factors and autonomic indices in relation to fatal and non-fatal coronary events
Christian Zambach, Artur Fedorowski, Yan Borné, Linda S B Johnson, Sofia Gerward, Viktor Hamrefors, Gunnar Engström

Open Heart Apr 2021, 8 (1) e001445; DOI: 10.1136/openhrt-2020-001445
Assessing the severity of cardiovascular disease in 213 088 patients with coronary heart disease: a retrospective cohort study
Salwa S Zghebi, Mamas A Mamas, Darren M Ashcroft, Martin K Rutter, Harm VanMarwijk, Chris Salisbury, Christian D Mallen, Caroline A Chew-Graham, Nadeem Qureshi, Stephen F Weng, Tim Holt, Iain Buchan, Niels Peek, Sally Giles, David Reeves, Evangelos Kontopantelis

Open Heart Apr 2021, 8 (1) e001498; DOI: 10.1136/openhrt-2020-001498
Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections
James J DiNicolantonio, Mark McCarty, Jorge Barroso-Aranda

Open Heart Mar 2021, 8 (1) e001568; DOI: 10.1136/openhrt-2020-001568

Main menu

Coronary Artery Disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Coronary Artery Disease

Pages